"gandotinib" meaning in All languages combined

See gandotinib on Wiktionary

Noun [English]

Head templates: {{en-noun|-}} gandotinib (uncountable)
  1. (pharmacology) An experimental medication belonging to the class of Janus kinase inhibitors. Tags: uncountable Categories (topical): Pharmaceutical drugs
    Sense id: en-gandotinib-en-noun-q~lYSPV8 Categories (other): English entries with incorrect language header Topics: medicine, pharmacology, sciences

Download JSON data for gandotinib meaning in All languages combined (1.7kB)

{
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "gandotinib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2172",
          "text": "Gandotinib is a JAK2-selective inhibitor that has potential increased potency for the JAK2 mutant kinase and has shown efficacy in myeloproliferative neoplasm (72), although there are currently no ongoing clinical investigations of gandotinib.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "An experimental medication belonging to the class of Janus kinase inhibitors."
      ],
      "id": "en-gandotinib-en-noun-q~lYSPV8",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "experimental",
          "experimental"
        ],
        [
          "medication",
          "medication"
        ],
        [
          "Janus kinase",
          "Janus kinase"
        ],
        [
          "inhibitor",
          "inhibitor"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) An experimental medication belonging to the class of Janus kinase inhibitors."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "gandotinib"
}
{
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "gandotinib (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms with quotations",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "examples": [
        {
          "ref": "2021 December, Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, Massimo Gadina, John J. O’Shea, “A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?”, in Arthritis & Rheumatology, volume 73, number 12, →DOI, page 2172",
          "text": "Gandotinib is a JAK2-selective inhibitor that has potential increased potency for the JAK2 mutant kinase and has shown efficacy in myeloproliferative neoplasm (72), although there are currently no ongoing clinical investigations of gandotinib.",
          "type": "quotation"
        }
      ],
      "glosses": [
        "An experimental medication belonging to the class of Janus kinase inhibitors."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "experimental",
          "experimental"
        ],
        [
          "medication",
          "medication"
        ],
        [
          "Janus kinase",
          "Janus kinase"
        ],
        [
          "inhibitor",
          "inhibitor"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) An experimental medication belonging to the class of Janus kinase inhibitors."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "word": "gandotinib"
}

This page is a part of the kaikki.org machine-readable All languages combined dictionary. This dictionary is based on structured data extracted on 2024-05-20 from the enwiktionary dump dated 2024-05-02 using wiktextract (1d5a7d1 and 304864d). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.